Tweenvest Stocks

Moberg Pharma AB (publ) (OM: MOB)

Health Care · Pharmaceuticals · SE

Skr11.38

+0.71% today · +37.4% 1Y

Moberg Pharma AB (publ) (OM: MOB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $53.32M and employs 5 people.

Over the last twelve months the share price has gained 37.4%, trading between 7.53 and 14.12.

Tweenvest scores Moberg Pharma AB (publ) across four factors: quality 50/100, value 76/100. Its strongest factor is value.

MOB price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$53.32M
Revenue (TTM)
$1.73M
P/E
—
EPS
-0.46
Dividend yield
—
Beta (5Y)
1.08
52-week high
Skr14.12
52-week low
Skr7.53
Avg volume (3M)
—
Shares outstanding
47.18M
Employees
5
Next earnings
—

About Moberg Pharma AB (publ)

Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to both crafting and globally marketing medical solutions throughout Europe, the United States, and various international territories. A notable product within its development portfolio is MOB-015, a treatment designed for nail fungus, which has successfully concluded its Phase III clinical trials. Established in 2006, this enterprise is headquartered in Bromma, Sweden. It was previously known as Moberg Derma AB (publ) until its rebranding to the current name in May 2013.

ISIN
SE0020353928
Founded
2006
Listed since
May 26, 2011
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
CTCBIO Inc.KOSDAQ: A060590$54.06M₩3,040.00-1.62%
Wai Yuen Tong Medicine Holdings LimitedSEHK: 897$53.96MHK$0.38+1.33%
Navana Pharmaceuticals PLCDSE: NAVANAPHAR$53.46MTk61.30-3.46%
Citi Pharma LimitedKASE: CPHL$53.43MPKRs64.76-9.88%
Odonate, Inc.OTCPK: ODTC$53.25M$——
Modern Chinese Medicine Group Co., Ltd.SEHK: 1643$53.21MHK$0.58-12.78%
Ildong Holdings Co., Ltd.KOSE: A000230$52.88M₩6,160.00-0.48%
Hyperion DeFi, Inc.NasdaqCM: HYPD$52.83M$3.54+4.12%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.